HCA Healthcare, Inc. (HCA) is listed on NYSE in the Healthcare sector Β· Medical Care Facilities industry. The current price is 411.02, up 2.23% from the previous close. Market cap is approximately $91.2B.
The commentary below is auto-generated by comparing market data (P/E, ROE, D/E, etc.) against predefined thresholds. No LLM is used. This is not a buy/sell recommendation from us or any analyst. For reference only.
HCA Healthcare, Inc. trades at a P/E of 14.18x, within the typical range for mature companies. Whether the multiple sits above or below the sector median is the cleaner relative-value read.
Revenue growth of 8.70% is in the single digits β a normal pace for mature businesses. Margin expansion and capital efficiency become the main EPS drivers.
HCA's 0.78% dividend yield is low. Check the dividend growth trend and payout ratio for room to expand.
Pharma and biotech are typically valued through risk-adjusted NPV/DCF on the pipeline.
HCA Healthcare, Inc. sits in the lower 28% of its 52-week range (353.99β556.52). The stock has pulled back from its highs; whether that reflects sector-wide conditions or a company-specific issue is the first thing to establish.
The stock moved within a 2.91% high-to-low band on the day, closing 2.23%. That falls within a typical intraday range.
HCA Healthcare, Inc. (HCA) is listed on NYSE, with recent volume of 535,559 shares. Volume is a supporting gauge of how much conviction sits behind a price move β the same gain reads differently on heavy versus light turnover.
Your watchlist and portfolio, one tap from your home screen β the Margin Call app